Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis.

Franz C, Hoffmann K, Hinz U, Singer R, Hund E, Gotthardt DN, Ganten T, Kristen AV, Hegenbart U, Schönland S, Hinderhofer K, Büchler MW, Schemmer P.

Clin Transplant. 2013 Jul-Aug;27 Suppl 25:40-8. doi: 10.1111/ctr.12193.

PMID:
23909501
2.

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.

Singer R, Mehrabi A, Schemmer P, Kashfi A, Hegenbart U, Goldschmidt H, Schönland S, Kristen A, Dengler T, Müller-Schilling M, Sauer P, Dogan A, Hund E, Helmke B, Schnabel P, Altland K, Linke R, Friess H, Schmidt J, Büchler MW, Kraus TW.

Transplantation. 2005 Sep 27;80(1 Suppl):S156-9.

PMID:
16286896
3.

Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.

Bittencourt PL, Couto CA, Farias AQ, Marchiori P, Bosco Massarollo PC, Mies S.

Liver Transpl. 2002 Jan;8(1):34-9.

4.
5.

Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.

Ohya Y, Okamoto S, Tasaki M, Ueda M, Jono H, Obayashi K, Takeda K, Okajima H, Asonuma K, Hara R, Tanihara H, Ando Y, Inomata Y.

Surg Today. 2011 Sep;41(9):1211-8. doi: 10.1007/s00595-010-4488-5. Epub 2011 Aug 26.

PMID:
21874417
6.

Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years.

Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, Söderdahl G, Wikström L, Ando Y, Suhr OB, Ericzon BG.

Am J Transplant. 2007 Nov;7(11):2597-604. Epub 2007 Sep 14.

7.

Outcome of liver transplantation for familial amyloidotic polyneuropathy.

Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V.

Liver Transpl. 2003 Dec;9(12):1273-80.

8.

Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.

Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A, Slama MS, Le Guludec D.

Medicine (Baltimore). 2006 Jul;85(4):229-38.

9.

The impact of obesity as determined by modified body mass index on long-term outcome after liver transplantation: Canadian single-center experience.

Tanaka T, Renner EL, Selzner N, Therapondos G, Lilly LB.

Transplant Proc. 2013 Jul-Aug;45(6):2288-94. doi: 10.1016/j.transproceed.2012.11.009.

PMID:
23953540
10.

Liver transplantation for familial amyloidotic polyneuropathy in Australia.

Nishino M, Tagaya N, Lynch SV, Steadman C, Balderson GA, Strong RW.

J Hepatobiliary Pancreat Surg. 2000;7(3):312-5.

PMID:
10982632
11.

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.

Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schäfers HJ, Galle PR, Otto G.

Liver Transpl. 2010 Mar;16(3):314-23. doi: 10.1002/lt.21996.

12.

Orthotopic liver transplantation for hereditary fibrinogen amyloidosis.

Zeldenrust S, Gertz M, Uemichi T, Björnsson J, Wiesner R, Schwab T, Benson M.

Transplantation. 2003 Feb 27;75(4):560-1.

PMID:
12605128
13.

Hereditary lysozyme amyloidosis -- phenotypic heterogeneity and the role of solid organ transplantation.

Sattianayagam PT, Gibbs SD, Rowczenio D, Pinney JH, Wechalekar AD, Gilbertson JA, Hawkins PN, Lachmann HJ, Gillmore JD.

J Intern Med. 2012 Jul;272(1):36-44. doi: 10.1111/j.1365-2796.2011.02470.x. Epub 2011 Nov 15.

14.

Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center.

Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Cescon M, Grazi GL, Salvi F, Magelli C, Grigioni F, Arpesella G, Martinelli G, Cavallari A.

Transplant Proc. 2004 Apr;36(3):645-7.

PMID:
15110620
15.

Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients.

Suhr OB, Holmgren G, Steen L, Wikström L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG.

Transplantation. 1995 Nov 15;60(9):933-8.

PMID:
7491696
16.

Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland.

Traynor CA, Tighe D, O'Brien FJ, Leavey SF, Dorman AM, Denton MD, Magee C, Conlon PJ.

Nephrology (Carlton). 2013 Aug;18(8):549-54. doi: 10.1111/nep.12108.

PMID:
23730806
17.

Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy.

Nelson LM, Penninga L, Sander K, Hansen PB, Villadsen GE, Rasmussen A, Gustafsson F.

Clin Transplant. 2013 Mar-Apr;27(2):203-9. doi: 10.1111/ctr.12053. Epub 2012 Dec 27.

PMID:
23278526
18.

Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.

Wixner J, Sundström T, Karling P, Anan I, Suhr OB.

BMC Gastroenterol. 2015 Apr 25;15:51. doi: 10.1186/s12876-015-0284-4.

19.

Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy.

Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala SO, Steen L.

Dig Dis Sci. 1996 Oct;41(10):1909-14.

PMID:
8888700
20.

Perioperative Predictors of Survival After Liver Transplantation for Familial Amyloid Polyneuropathy in a Portuguese Center.

Lagarto F, Gomes B, Couto PS, Correia de Barros F, Moreira Z, Branco T, Fonseca L, Aguiar J, Aragão I, Miranda HP, Daniel J, Esteves S.

Transplant Proc. 2016 Jul-Aug;48(6):2098-101. doi: 10.1016/j.transproceed.2016.04.020.

PMID:
27569952

Supplemental Content

Support Center